-
2023-506631-15-00
Patients with invasive breast cancer, on stage I-III, a 5 2024-04-15
-
2023-504865-21-00
Essential Thrombocythemia patients who have an inadequa 5 2024-04-15
-
2023-505361-86-00
Myocardial infarction 6 2024-04-12
-
2024-512829-81-00
Adult patients treated in VA ECMO/Impella for cardiogen 4 2024-04-10
-
2023-506283-13-00
Chronic heart failure with reduced ejection fraction 6 2024-04-09
-
2023-505871-63-00
ER+, HER2- metastatic breast cancer following endocrine 5 2024-04-08
-
2023-505375-75-00
Onset of Atrial Fibrillation and Acute Kidney Injury af 5 2024-04-04
-
2023-508298-10-00
Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt) 4 2024-04-01
-
2024-517610-15-00
hyperuricemia, hypertension, ischemic stroke, intracere 5 2024-03-28
-
2022-503135-33-00
Subclinical heart failure 6 2024-03-26
-
2023-504756-96-00
Recurrent pericarditis, idiopathic or secondary to inva 5 2024-03-22
-
2022-503010-23-01
Heart Failure 6 2024-03-20
-
2023-505855-32-01
Cardiovascular pathology 6 2024-03-20
-
2023-503753-35-01
Obesity and Heart Failure with reduced Ejection Fraciti 4 2024-03-20
-
2023-505239-10-00
Primary (essential) hypertension 6 2024-03-19
-
2023-508515-23-00
atherothrombotic and thromboembolic disorders 3 2024-03-19
-
2024-512658-41-00
Congestive Heart Failure 10 2024-03-06
-
2024-510892-40-00
Acute myocardial infarction complicated by cardiogenic 6 2024-02-29
-
2023-504835-42-00
Heart Failure (Heart Failure with Reduced Ejection Frac 4 2024-02-29
-
2022-502986-92-00
Atrial fibrillation 6 2024-02-27
-
2024-516402-32-00
Adult patients with aHUS associated with HE and severe 5 2024-02-13
-
2024-515059-39-00
Marfan Syndrome
Diseases related to Marfan syndrome (ra 5 2024-02-09
-
2023-505287-11-01
Critical limb ischemia 3 2024-02-01
-
2022-502500-75-00
Atrial fibrillation 6 2024-01-30